Cited Evidence for Differential Diagnosis of Massive Lymphocyte‑Rich Pleural Effusions

Malignant Effusions

Malignant disease accounts for 42–77 % of all exudative pleural effusions and is markedly more common when the effusion is massive rather than small. 1
Lung carcinoma is responsible for ≈ ⅓ of all malignant pleural effusions, making it the leading cancer cause. 1
Breast carcinoma is the second most frequent malignancy producing lymphocyte‑predominant effusions. 1
Hodgkin’s and non‑Hodgkin’s lymphomas together represent ≈ 10 % of malignant pleural effusions and characteristically yield lymphocyte‑rich exudates. 1
Multiple myeloma causes pleural effusions in ≈ 6 % of cases, typically with high pleural protein concentrations. 1
About one‑third of malignant effusions have pleural fluid pH < 7.30, a finding that correlates with poorer survival. 2, 3, 4
The nucleated cell count in malignant effusions usually shows lymphocyte or other mononuclear predominance. 2, 3, 4

Tuberculosis is the most common infectious cause of lymphocyte‑rich exudative effusions, accounting for ≈ 12 % of massive pleural effusions. 1
Adenosine deaminase (ADA) > 35–45 U/L with > 50 % lymphocytes strongly suggests tuberculous pleuritis. 5
On thoracic ultrasound, tuberculous effusions are highly complex with internal septations, a pattern that differs from typical malignant effusions. 6
Chest CT in TB may show circumferential pleural thickening > 1 cm, mediastinal surface involvement, and nodularity, but no chest‑wall invasion (a feature more typical of malignancy). 6
Empirical anti‑tuberculous therapy can be justified when a positive tuberculin skin test accompanies an exudative, lymphocyte‑predominant effusion in the appropriate clinical setting. 1

Complicated parapneumonic effusions/empyema represent 10–22 % of massive pleural effusions and usually show neutrophil predominance (> 50 %). 7
Pleural fluid pH < 7.20 and glucose < 60 mg/dL are diagnostic thresholds indicating a complicated infection that requires immediate drainage. 7, 5

Findings favoring infection (vs. malignancy):

Lentiform (lentil‑shaped) configuration of fluid, visceral pleural thickening (“split‑pleura sign”), extrapleural fat hypertrophy > 2 mm, increased density of extrapleural fat, and associated pulmonary consolidation. 6

Findings suggesting malignancy:

Circumferential pleural thickening with mediastinal involvement, chest‑wall invasion, a mass involving extrapleural fat, and diaphragmatic or parietal pleural nodularity on ultrasound. 6, 1

Ultrasound‑guided thoracentesis reduces the risk of iatrogenic pneumothorax. 5
Obtaining 25–50 mL of pleural fluid provides optimal diagnostic yield. 5
Core pleural fluid analyses should include protein, LDH, pH, glucose, and cell‑count differential. 5
Microbiologic work‑up must comprise Gram stain, acid‑fast bacilli stain, and bacterial cultures (including blood‑culture bottles). 5
Cytology detects malignancy in ≈ 80 % of cases overall, but sensitivity drops to 31–55 % for lymphoma. 1
Thoracoscopy offers superior tissue diagnosis, especially for lymphoma, with ≈ 85 % sensitivity when chromosome analysis is performed. 1
Pleural biopsy is strongly recommended when tuberculosis is suspected, achieving 69–97 % sensitivity. 5

Malignancy can coexist with pleural infection in ≈ 5 % of patients; therefore, follow‑up imaging for up to 2 years is advised when clinical concern persists. 6
Diagnostic bronchoscopy should be reserved for patients with hemoptysis or radiologic features of bronchial obstruction. 5
A thorough occupational history (including asbestos exposure) is essential because mesothelioma must be considered in massive effusions. 1
In cases of persistent undiagnosed effusion, clinicians should re‑evaluate for pulmonary embolism and tuberculosis, both of which have specific, treatable therapies. 5, 1

Late pleural effusions occurring more than 15 days after solid‑organ transplantation are typically exudative and lymphocyte‑predominant. 8

A pleural fluid pH < 7.20 combined with glucose < 60 mg/dL defines a complicated parapneumonic effusion that requires immediate drainage, even when the effusion is lymphocyte‑predominant. 9
Placing pleural fluid in anaerobic blood‑culture bottles markedly improves microbiologic yield for detecting anaerobic pathogens. 9

The European Respiratory Society recommends medical thoracoscopy as the gold‑standard and final diagnostic step for unexplained exudative pleural effusions. 10
Nonspecific pleuritis is identified in up to 40 % of thoracoscopic pleural biopsies; of these cases, approximately 8 % are later proven malignant, most frequently mesothelioma. 10

Detection of homozygous deletion of CDKN2A by fluorescence in‑situ hybridisation (FISH) provides 100 % specificity for mesothelioma. 10
Loss of BAP1 expression on immunohistochemistry is a highly specific ancillary marker supporting a diagnosis of mesothelioma. 10